Canadian Pharmaceuticals & Biotech Most Popular Stocks

Curaleaf Holdings

Market Cap: CA$2.6b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.1b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$1.6b

Operates as a cannabis retailer in the United States.

Cronos Group

Market Cap: CA$1.3b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bright Minds Biosciences

Market Cap: CA$1.1b

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Knight Therapeutics

Market Cap: CA$738.2m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Vireo Growth

Market Cap: CA$632.2m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Cresco Labs

Market Cap: CA$614.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Verano Holdings

Market Cap: CA$582.9m

Engages in the cannabis business in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$581.8m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Canopy Growth

Market Cap: CA$537.0m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Cipher Pharmaceuticals

Market Cap: CA$456.5m

Operates as a specialty pharmaceutical company in Canada.

Spectral Medical

Market Cap: CA$399.0m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

TerrAscend

Market Cap: CA$330.0m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

High Tide

Market Cap: CA$280.4m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Aurora Cannabis

Market Cap: CA$270.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Organigram Global

Market Cap: CA$263.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Cardiol Therapeutics

Market Cap: CA$200.3m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Auxly Cannabis Group

Market Cap: CA$182.7m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Satellos Bioscience

Market Cap: CA$180.2m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

BioSyent

Market Cap: CA$168.2m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Helix BioPharma

Market Cap: CA$139.0m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

HLS Therapeutics

Market Cap: CA$136.7m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

Charlotte's Web Holdings

Market Cap: CA$130.0m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Noveris Health Sciences

Market Cap: CA$128.8m

A biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions.

Medexus Pharmaceuticals

Market Cap: CA$116.5m

Operates as a pharmaceutical company in Canada and the United States.

Atlas Energy

Market Cap: CA$107.0m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Grown Rogue International

Market Cap: CA$100.0m

A craft cannabis company, focuses on premium flower and flower-derived products.

ME Therapeutics Holdings

Market Cap: CA$75.1m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Decibel Cannabis

Market Cap: CA$72.1m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Planet 13 Holdings

Market Cap: CA$70.6m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Vext Science

Market Cap: CA$66.5m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Sharp Therapeutics

Market Cap: CA$64.7m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

BioNxt Solutions

Market Cap: CA$62.2m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

NurExone Biologic

Market Cap: CA$61.7m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

Sernova Biotherapeutics

Market Cap: CA$57.8m

Operates as a clinical-stage biotechnology company in Canada.